State Street Corp Purchases 95,613 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

State Street Corp grew its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 3.5% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,819,911 shares of the company's stock after purchasing an additional 95,613 shares during the quarter. State Street Corp owned approximately 3.04% of Acadia Healthcare worth $178,811,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Blue Trust Inc. increased its holdings in Acadia Healthcare by 86.1% during the second quarter. Blue Trust Inc. now owns 536 shares of the company's stock worth $36,000 after buying an additional 248 shares during the last quarter. GAMMA Investing LLC increased its stake in shares of Acadia Healthcare by 57.1% during the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company's stock worth $42,000 after purchasing an additional 241 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of Acadia Healthcare in the 2nd quarter worth approximately $59,000. Covestor Ltd lifted its stake in Acadia Healthcare by 834.4% in the third quarter. Covestor Ltd now owns 1,140 shares of the company's stock valued at $72,000 after purchasing an additional 1,018 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale bought a new position in Acadia Healthcare during the third quarter valued at $86,000.

Acadia Healthcare Price Performance

Shares of ACHC traded up $0.32 during mid-day trading on Friday, reaching $40.66. 1,084,705 shares of the stock traded hands, compared to its average volume of 1,039,865. The company has a market cap of $3.78 billion, a price-to-earnings ratio of 13.33, a price-to-earnings-growth ratio of 1.77 and a beta of 1.29. Acadia Healthcare Company, Inc. has a 1 year low of $36.50 and a 1 year high of $87.77. The firm has a fifty day moving average price of $45.39 and a 200 day moving average price of $61.82. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its earnings results on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. The business had revenue of $815.60 million during the quarter, compared to analysts' expectations of $819.42 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The firm's revenue was up 8.7% on a year-over-year basis. During the same period in the previous year, the business earned $0.91 earnings per share. As a group, equities research analysts predict that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

Analysts Set New Price Targets

Several brokerages have issued reports on ACHC. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a "hold" rating to a "buy" rating and boosted their target price for the company from $45.00 to $75.00 in a research note on Thursday. KeyCorp assumed coverage on shares of Acadia Healthcare in a report on Friday, October 11th. They set a "sector weight" rating on the stock. Barclays reduced their target price on shares of Acadia Healthcare from $76.00 to $43.00 and set an "overweight" rating for the company in a research note on Friday, November 22nd. StockNews.com cut shares of Acadia Healthcare from a "hold" rating to a "sell" rating in a research note on Friday, November 22nd. Finally, Cantor Fitzgerald reissued a "neutral" rating and set a $52.00 target price on shares of Acadia Healthcare in a report on Tuesday. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have assigned a buy rating to the company. According to MarketBeat.com, Acadia Healthcare currently has an average rating of "Moderate Buy" and an average price target of $75.44.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.